That is very different than saying the extension study added nothing new.
It is big news considering it was increased dosage that provided NEW clinical data that was requested by potential partners. The only way you can take the position that the extension study was insignificant is if you believe Tim fabricated the whole story.
Ann: Corporate Presentation, page-100
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $11.51M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $10.44K | 549.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 561999 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 631544 | 3 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| 1AD (ASX) Chart |